Search

everythinglearnresearchcommunity

for

Search:↓

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Finasteride can cause sexual problems and depression in young men.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Excessive selenium from a supplement caused toxicity but patients recovered with care.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Bicalutamide may help treat female pattern hair loss.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

PRP shows promise but lacks consistent evidence and regulation.

New understanding and treatments for hair loss are improving, but more research is needed.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Acne is a chronic skin condition not caused by poor hygiene or diet, and it requires long-term treatment and patient education.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.